Ansa Biotechnologies, Inc.

When the Gao lab needed to generate some repetitive protein sequences in order to create and optimize engineered cells via RNA delivery, they couldn't rely on their typical cloning workflow. And when they tried to get the sequences synthesized elsewhere, they were told it couldn't be done. Enter Ansa. Within a week, on the first try, the Ansa team was to able to deliver. Hear more about the project and how the lab overcame several challenges and improved its workflow in this webinar with lab member Connor C.. ?? Watch now, on demand: https://lnkd.in/eb9NFWtH #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #AnsamerAnswers #RELEASE #webinar #genetics #RNAtherapeutics

?? We’re hiring a Director of Product Management! ?? At Ansa Biotechnologies, we are transforming life science research with our innovative approach to DNA synthesis. We are seeking a driven and dedicated Director of Product Management to join our dynamic team at the forefront of synthetic biology. In this role, you will be responsible for guiding the development and launch of innovative products that meet customer needs and drive business growth. If you’re passionate about pushing the boundaries of science, making a global impact, and joining a culture of innovation, apply to join our team! https://lnkd.in/g4tDCwmP

Science moves fast—so why is DNA synthesis stuck in the slow lane? Long turnaround times, failed orders, and delays shouldn’t be the price of admission for researchers pushing the boundaries of cell and gene therapy. As Dan points out in this Medicine Maker piece, “we cannot realize the full potential of cell and gene therapies without being able to explore a broader design space – and reliably get the actual DNA we want to test all of those interesting ideas.” That’s exactly why we’re shaking things up at Ansa Biotechnologies, Inc. Because bad DNA synthesis shouldn’t be holding back great science. Give this a read!

Designing gene sequences on a computer is one thing. Actually making them is another. Construction of DNA molecules longer than a few hundred base pairs can be a daunting, if not impossible task, especially when they include challenging elements like repeats or complex guanine-cytosine (GC) content. Ansa co-founder and CSO, Daniel Lin-Arlow shares his insights and advice for scientists on how to overcome some of the challenges of DNA synthesis, including complexity, turnaround time & quality control. ?? Read The Medicine Maker article:? https://lnkd.in/eQSprrA3 #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #AnsamerAnswers

Some folks were surprised when I left academia back in 2018 to co-found a company focused on DNA synthesis. "Gene synthesis and cloning technologies? Aren't those just boring tools, a means to an end?" Well, 6.5 years later, I can tell you it's been anything but boring - and the excitement is only growing. Let me take you back: In my early grad school days, before gblocks and Gibson assembly, building custom plasmids could be a months-long odyssey. Even as the field evolved with companies like Twist leveraging million-oligo printers and machine learning, fundamental challenges persisted - delayed orders, sequence restrictions, and endless cloning. Then came the turning point: reading my future co-founders Dan and Sebastian's Nature Biotechnology paper on enzymatic oligo synthesis. With my background in high-throughput polymerase engineering, I saw the potential. The hypothesis was simple yet powerful: enzymes could outperform chemistry in DNA synthesis. And considering that DNA synthesis underpins virtually every advancement in pharma and biotech, even a 5% improvement in research efficiency could be transformative. Today, we've turned that vision into reality at Ansa. We're producing the world's highest quality and longest oligos, enabling our customers to access complex DNA sequences that were previously out of reach. But what truly excites me? This is just the beginning. We're rapidly innovating to make DNA synthesis so reliable that researchers will never have to see it as a bottleneck again. Sometimes the most exciting innovations come from reimagining the fundamentals. Who knew "boring" could be so revolutionary? Check us out @ ansabio.com

Don't miss the Genomics Showcase Fair today at the Mission Bay Conference Center! Drop by the Ansa Biotechnologies table where you can learn how to accelerate your research by letting us synthesize your most complex DNA sequences.

??? Charting new territory in DNA synthesis requires a highly motivated, multidisciplinary team and a culture of innovation where people don’t feel constrained by staying in their lanes. Ansa co-founder and CSO Daniel Lin-Arlow talks about how this approach has helped Ansa come up with some creative solutions to complex challenges, starting with a new “dipping” method used in our synthesizers, in our latest blog: how:https://lnkd.in/eKhdjpHs #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA

The importance of DNA synthesis has been historically underestimated, but the potential when unleashed is boundless. It's why Ansa co-founder and Chief Technology Officer Sebastian Palluk was so committed to improving upon legacy chemical DNA synthesis methods using enzymes. ?? Check out our latest blog post, where he discusses the enzymatic process that has made it possible to synthesize the long, complex DNA that scientists need: how:https://lnkd.in/eKhdjpHs #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA

?? It may be "complex" to us, but it's just normal DNA to nature. Nature's elegant solutions to genetic design and function may be difficult to manufacture using legacy technology, but that's all the more reason why Ansa continues to innovate in how we synthesize DNA, argues Jared Ellefson. ?? See what else the Ansa co-founder and head of DNA assembly had to say about the topic on our blog:?https://lnkd.in/eKhdjpHs #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA

The Ansa Biotechnologies team is ready for the holidays! From all of us, we wish you a season full of warmth, joy, and groundbreaking discoveries. Cheers to 2025! ?? #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA? #customDNA #HappyHolidays